Spinal Muscular Atrophy Carrier Numbers On The Rise, Treatment Developments To Be Expedited
Ionis Pharma Solution Could Vastly Improve SMA Treatment
ISIS-SMNRx is a drug being developed by Ionis Pharmaceuticals for the treatment of spinal muscular atrophy. As of 2015, it was the only drug that had reached phase 3 of clinical trials. The studies are expected to be completed by July 2017.
Obtain Report Details @ http://www.transparencymarketresearch.com/spinal-muscular-atrophy-market.html
“Should this drug be approved for the treatment of spinal muscular atrophy, it will create a highly lucrative opportunity for both Ionis Pharma and Biogen Idec,” states a TMR analyst. “This drug is expected to be released in 2018 and hold high expectations from the healthcare industry for the treatment of spinal muscular atrophy.”
Growing SMA Carrier Frequency Speeds up Solutions R&D
One of the key drivers affecting the growth of the market for spinal muscular atrophy drugs is the increasing number of carriers of the defective SMA gene. As per the findings revealed by CureSMA, nearly one out of 50 people are carrying the SMA defect. Additionally, this statistic does not include a majority of the global population that for various reasons could not be included in the study. The total percentage of SMA gene carriers could therefore be effectively higher than previously mentioned.
This is creating a greater urge for healthcare and pharmaceutical organizations to create feasible solutions to treat spinal muscular atrophy, and is also pushing the organizations to increase awareness rates of SMA among people.
Lack of Advanced Research Slows Overall Development of SMA Treatments
There are currently multiple research institutes and government agencies that are working together to keep the total number of SMA cases in check. They do not, however, distinguish between the various types of spinal muscular atrophy afflicting the patients. This reduces the accuracy of patient diagnosis and eventually reduces the overall rate of development of treatments for spinal muscular atrophy. At the same time, it makes disease mapping for trends extremely difficult.
The resultant lack of research is therefore hindering the chances of innovative treatment solutions and the identification of disease progression.
Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7187
Large Areas Still Untapped for SMA Treatment to Provide Key Opportunities
The U.S. and Europe have designated SMA as an orphan disease. Between the U.S., Europe and Japan, between 25,000 and 50,000 people were diagnosed with spinal muscular atrophy as of June 2015, according to European Pharmaceutical Reviews. The total number of spinal muscular atrophy patients across the world is as yet unknown.
The absence of an approved drug-based treatment for spinal muscular atrophy combined with the unknown number of SMA patients leaves a major unrealized market for SMA drugs that can be tapped into for greater opportunities.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spinal Muscular Atrophy Carrier Numbers On The Rise, Treatment Developments To Be Expedited here
News-ID: 600374 • Views: 233
More Releases from Transparency Market Research
Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals
More Releases for SMA
Spinal Muscular Atrophy Market | SMA Treatment Market | PBIGP
Spinal Muscular Atrophy Management Market is Expected to Increase Around US$ XX Mn by 2025, Due to Inherited Diseases that Affects the Functioning of Muscles Because of Deterioration. Analyst Speak: “The Spinal Muscular Atrophy Management Market is anticipated to reach about US$ XX Mn by 2024, and anticipated to expand at a CAGR over seven years of forecast period 2019-2025” due to increased inherited diseases that affects the normal functioning of
Global Hybrid Power Systems Market 2018 - Siemens, Emerson, Heliocentris, SMA
Accord Market, recently published a detailed market research study focused on the “Hybrid Power Systems Market” across the global, regional and country level. The report provides 360° analysis of “Hybrid Power Systems Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Hybrid Power
Sunny Sky Solar Is Providing SMA Inverters for Solar Panels
Sunny Sky Solar provides the best solar products from manufacturers of repute and whose products are independently tested and are proven to be trustworthy. The Brisbane based company has succeeded in an industry with fierce competition because they sell quality solar products that are robust and sell at reasonable prices. The Company has a team of qualified experts who work to install the solar products professionally for the client. All
Global Solar Microinverter Market 2018 - SMA, Sungrow, SunPower, Samil Power
The statistical surveying information incorporated into the Solar Microinverter report is the aftereffect of significant essential and optional research exercises. The report fragments the global market for Solar Microinverter based on makers, item compose, applications, and districts. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the global Solar Microinverter advertise covering key factors, for example, drivers and
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2017, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a genetic disease that attacks nerve
Antidepressant Drugs Market- GSK, Pfizer, Lundbeck, Teva Pharmaceutical, SMA
Global Antidepressant Drugs Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Antidepressant Drugs Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GSK Pfizer Lundbeck Teva Pharmaceutical SMA Eli Lilly and Company Forest Laboratories Schering-Plough Novartis Sanofi Enquiry for buying report @ https://goo.gl/szzxan The Global Antidepressant Drugs report gives a thorough situation of the present and gauge Antidepressant Drugs showcase procedures,